Ototoxicity in locally advanced head and neck cancer patients treated with induction chemotherapy followed by intermediate or high‐dose cisplatin‐based chemoradiotherapy

Determinants of ototoxicity in 451 platinum-treated Dutch survivors of childhood cancer: A DCOG late-effects study

(2016) Eva Clemens et al.   EUROPEAN JOURNAL OF CANCER

Induction chemotherapy with docetaxel/cisplatin/5-fluorouracil followed by randomization to two cisplatin-based concomitant chemoradiotherapy schedules in patients with locally advanced head and neck cancer (CONDOR study) (Dutch Head and Neck Society 08-01): A randomized phase II study

(2016) C.M.L. Driessen et al.   EUROPEAN JOURNAL OF CANCER

Replication of a genetic variant in ACYP2 associated with cisplatin-induced hearing loss in patients with osteosarcoma

(2016) Hanneke I. Vos et al.   Pharmacogenetics and Genomics

Hearing and tinnitus in head and neck cancer patients after chemoradiotherapy

(2015) Riina Niemensivu et al.   EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY

Degree of nephrotoxicity after intermediate- or high-dose cisplatin-based chemoradiotherapy in patients with locally advanced head and neck cancer

(2015) Chantal M. L. Driessen et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Toxicity and efficacy of accelerated radiotherapy with concurrent weekly cisplatin for locally advanced head and neck carcinoma

(2015) Chantal M. L. Driessen et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Influence of Genetic Variants in TPMT and COMT Associated with Cisplatin Induced Hearing Loss in Patients with Cancer: Two New Cohorts and a Meta-Analysis Reveal Significant Heterogeneity between Cohorts

(2015) Melanie M. Hagleitner et al.   PLoS One

Hearing evaluation of patients with head and neck cancer: Comparison of Common Terminology Criteria for Adverse Events, Brock and Chang adverse event criteria in patients receiving cisplatin

(2014) A. Dimitrios Colevas et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Long-term hearing loss after chemoradiation in patients with head and neck cancer

(2014) Eleonoor A. R. Theunissen et al.   LARYNGOSCOPE

Genetic variation in Otos is associated with cisplatin-induced ototoxicity

(2014) Timothy F Spracklen et al.   PHARMACOGENOMICS

Sensorineural hearing loss in patients with head and neck cancer after chemoradiotherapy and radiotherapy: A systematic review of the literature

(2013) Eleonoor A. R. Theunissen et al.   HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK

Weekly and 3-weekly cisplatin concurrent with intensity-modulated radiotherapy in locally advanced head and neck squamous cell cancer

(2011) V. Espeli et al.   ORAL ONCOLOGY

Pharmacogenomics of cisplatin-induced ototoxicity

(2011) Debashree Mukherjea et al.   PHARMACOGENOMICS

Genetic variants in TPMT and COMT are associated with hearing loss in children receiving cisplatin chemotherapy

(2009) Colin J D Ross et al.   NATURE GENETICS

Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 93 randomised trials and 17,346 patients

(2009) Jean-Pierre Pignon et al.   RADIOTHERAPY AND ONCOLOGY

Hearing loss due to concurrent daily low-dose cisplatin chemoradiation for locally advanced head and neck cancer

(2008) Charlotte L. Zuur et al.   RADIOTHERAPY AND ONCOLOGY